Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification

Posterior capsular opacification (PCO) is the most common long-term complication of cataract surgery. Traditionally, the pathogenesis of PCO involves the residual lens epithelial cells (LECs), which undergo transdifferentiation into a myofibroblast phenotype, hyperproliferation, matrix contraction,...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenshuang Li, Weijia Yan, Hong Yan
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/13/10/1210
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850205282016165888
author Chenshuang Li
Weijia Yan
Hong Yan
author_facet Chenshuang Li
Weijia Yan
Hong Yan
author_sort Chenshuang Li
collection DOAJ
description Posterior capsular opacification (PCO) is the most common long-term complication of cataract surgery. Traditionally, the pathogenesis of PCO involves the residual lens epithelial cells (LECs), which undergo transdifferentiation into a myofibroblast phenotype, hyperproliferation, matrix contraction, and matrix deposition. This process is driven by the marked upregulation of inflammatory and growth factors post-surgery. Recently, research on the role of redox environments has gained considerable attention. LECs, which are in direct contact with the aqueous humour after cataract surgery, are subjected to oxidative stress due to decreased levels of reduced glutathione and increased oxygen content compared to contact with the outer fibre layer of the lens before surgery. In this review, we examine the critical role of oxidative stress in PCO formation. We also focus on glutaredoxins (Grxs), which are antioxidative enzymes produced via deglutathionylation, their protective role against PCO formation, and their therapeutic potential. Furthermore, we discuss the latest advancements in PCO therapy, particularly the development of advanced antioxidative pharmacological agents, and emphasise the importance and approaches of anti-inflammatory and antioxidant treatments in PCO management. In conclusion, this review highlights the significant roles of oxidative stress in PCO, the protective effects of Grxs against PCO formation, and the potential of anti-inflammatory and antioxidant therapies in treating PCO.
format Article
id doaj-art-4502acc0b4a14871b49397a956ca06d2
institution OA Journals
issn 2076-3921
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj-art-4502acc0b4a14871b49397a956ca06d22025-08-20T02:11:08ZengMDPI AGAntioxidants2076-39212024-10-011310121010.3390/antiox13101210Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular OpacificationChenshuang Li0Weijia Yan1Hong Yan2Shaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, ChinaEye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang University Eye Hospital, Hangzhou 310009, ChinaShaanxi Eye Hospital, Xi’an People’s Hospital (Xi’an Fourth Hospital), Affiliated People’s Hospital of Northwest University, Xi’an 710004, ChinaPosterior capsular opacification (PCO) is the most common long-term complication of cataract surgery. Traditionally, the pathogenesis of PCO involves the residual lens epithelial cells (LECs), which undergo transdifferentiation into a myofibroblast phenotype, hyperproliferation, matrix contraction, and matrix deposition. This process is driven by the marked upregulation of inflammatory and growth factors post-surgery. Recently, research on the role of redox environments has gained considerable attention. LECs, which are in direct contact with the aqueous humour after cataract surgery, are subjected to oxidative stress due to decreased levels of reduced glutathione and increased oxygen content compared to contact with the outer fibre layer of the lens before surgery. In this review, we examine the critical role of oxidative stress in PCO formation. We also focus on glutaredoxins (Grxs), which are antioxidative enzymes produced via deglutathionylation, their protective role against PCO formation, and their therapeutic potential. Furthermore, we discuss the latest advancements in PCO therapy, particularly the development of advanced antioxidative pharmacological agents, and emphasise the importance and approaches of anti-inflammatory and antioxidant treatments in PCO management. In conclusion, this review highlights the significant roles of oxidative stress in PCO, the protective effects of Grxs against PCO formation, and the potential of anti-inflammatory and antioxidant therapies in treating PCO.https://www.mdpi.com/2076-3921/13/10/1210posterior capsular opacificationepidemiologypathogenesisoxidative stressglutaredoxinsadvanced antioxidative pharmacological agent
spellingShingle Chenshuang Li
Weijia Yan
Hong Yan
Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification
Antioxidants
posterior capsular opacification
epidemiology
pathogenesis
oxidative stress
glutaredoxins
advanced antioxidative pharmacological agent
title Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification
title_full Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification
title_fullStr Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification
title_full_unstemmed Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification
title_short Oxidative Stress, Glutaredoxins, and Their Therapeutic Potential in Posterior Capsular Opacification
title_sort oxidative stress glutaredoxins and their therapeutic potential in posterior capsular opacification
topic posterior capsular opacification
epidemiology
pathogenesis
oxidative stress
glutaredoxins
advanced antioxidative pharmacological agent
url https://www.mdpi.com/2076-3921/13/10/1210
work_keys_str_mv AT chenshuangli oxidativestressglutaredoxinsandtheirtherapeuticpotentialinposteriorcapsularopacification
AT weijiayan oxidativestressglutaredoxinsandtheirtherapeuticpotentialinposteriorcapsularopacification
AT hongyan oxidativestressglutaredoxinsandtheirtherapeuticpotentialinposteriorcapsularopacification